Table 1.
Clinical characteristics of the study population of coronary artery disease patients with and without known type 2 diabetes, n = 865.
Table 2.
Clinical characteristics of coronary artery disease patients with and without prediabetes, n = 620.
Fig 1.
Platelet aggregation in patients with coronary artery disease; 307 patients without diabetes (HbA1c < 5.7%) and 303 patients with prediabetes (HbA1c 5.7–6.4%). Platelet aggregation induced by A) arachidonic acid and B) collagen as agonists using Multiplate Analyzer. Median and interquartile ranges are indicated.
Fig 2.
Correlation between haemoglobin A1c and platelet aggregation and platelet turnover.
Correlation between HbA1c and A) platelet aggregation induced by arachidonic acid 1.0 mM and B) immature platelet count in patients with coronary artery disease (n = 861). Patients without diabetes (no antidiabetic drugs, n = 620) are marked with light grey and patients with type 2 diabetes (on antidiabetic drugs, n = 241) are marked in dark grey.
Table 3.
Correlation between HbA1c and platelet parameters in coronary artery disease patients, n = 861*.